nimodipine has been researched along with Nicotine Addiction in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biala, G | 2 |
| Budzynska, B | 2 |
2 other studies available for nimodipine and Nicotine Addiction
| Article | Year |
|---|---|
Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists.
Topics: Animals; Behavior, Animal; Calcium Channel Blockers; Conditioning, Psychological; Extinction, Psycho | 2006 |
Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats.
Topics: Animals; Benzoxazines; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Central Nervous | 2008 |